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The effects of anatabine on non-invasive
indicators of muscle damage: a randomized,
double-blind, placebo-controlled, crossover study
Nathaniel DM Jenkins, Terry J Housh, Glen O Johnson, Daniel A Traylor, Haley C Bergstrom, Kristen C Cochrane,
Robert W Lewis, Jr., Richard J Schmidt and Joel T Cramer*
Abstract
Background: Anatabine (ANA), a minor tobacco alkaloid found in the Solanaceae family of plants, may exhibit
anti-inflammatory activity, which may be useful to aid in recovery from exercise-induced muscle damage. The
purpose of this study, therefore, was to examine the effects of ANA supplementation on the recovery of isometric
strength and selected non-invasive indicators of muscle damage.
Methods: A double-blinded, placebo-controlled, crossover design was used to study eighteen men (mean ± SD
age = 22.2 ± 3.1 yrs; body mass = 80.3 ± 15.7 kg) who participated in two randomly-ordered conditions separated by
a washout period. The ANA condition consisted of consuming 6–12 mg anatabine per day for 10 days, while
testing took place during days 7–10. The placebo (PLA) condition was identical except that the PLA supplement
contained no ANA. Maximal voluntary isometric peak torque (PT) of the forearm flexors, arm circumference,
hanging joint angle, and subjective pain ratings were measured before (PRE), immediately after (POST), and 24, 48,
and 72 h after six sets of 10 maximal, eccentric isokinetic forearm flexion muscle actions. Resting heart rate and
blood pressure were measured at PRE and 72 h in each condition.
Results: For PT, hanging joint angle, arm circumference, and subjective pain ratings, there were no condition x
time (p > 0.05) interactions, there were no main effects for condition (p > 0.05), but there were main effects for time
(p < 0.001). There were no condition x time (p > 0.05) interactions and no main effects for condition (p > 0.05) or
time (p > 0.05) for blood pressure or resting heart rate.
Conclusions: ANA supplementation had no effect on the recovery of muscle strength, hanging joint angle, arm
swelling, or subjective pain ratings after a bout of maximal eccentric exercise in the forearm flexors. Therefore, ANA
may not be beneficial for those seeking to improve recovery from heavy eccentric exercise. Future studies should
examine the effects of ANA on the pro-inflammatory cytokine responses to exercise-induced muscle damage and
the chronic low-grade inflammation observed in obese and elderly individuals.
Keywords: Anatabine, Supplementation, Eccentric muscle damage, Delayed onset muscle soreness,
Muscle function
Background
Unaccustomed eccentric exercise often results in
muscle damage and delayed onset muscle soreness
(DOMS). The symptoms of eccentric-induced muscle
damage include loss of strength, limited range of mo-
tion, swelling, pain, and tenderness [1,2]. While the
exact mechanisms responsible for these symptoms are
not fully understood, the structural damage caused by
eccentric exercise is characterized by disorganization of
myofilaments, z-line widening and streaming [3,4], inter-
ruption of the excitation-contraction coupling process [5],
and an immune response that produces an accumulation
of mononuclear cells [1]. It is also possible that neural
mechanisms, such as the inability to fully activate muscles,
may contribute to the loss of strength following eccentric
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exercise [6,7]. Thus, several factors contribute to the mani-
festation of eccentric-induced symptoms of muscle damage
and DOMS. As a result, studies have examined a variety of
treatments to reduce damage or improve recovery after ec-
centric exercise, such as therapeutic modalities (i.e., mas-
sage, cryotherapy, and stretching), pharmacological
treatments (i.e., non-steroidal anti-inflammatory drugs),
and dietary supplementation.
Lund et al. [8] showed no effects of passive stretching
on muscle strength or muscle pain after eccentric-
induced muscle damage in the leg extensors. Tokmakidis
et al. [9] demonstrated that ibuprofen (400 mg every
8 hours for 48 hrs) decreased muscle soreness at 24 h
after eccentric exercise, however, there were no differ-
ences in the recovery of muscle strength or range of mo-
tion compared to placebo. In addition, Connolly et al.
[10] found that tart cherry juice supplementation attenu-
ated the losses in muscle strength and decreased muscle
pain after eccentric-induced muscle damage when com-
pared to a placebo. Consequently, treatments that may
reduce inflammation can help to improve recovery or al-
leviate the symptoms associated with exercise-induced
muscle damage.
Anatabine (ANA) is a minor alkaloid with a similar
chemical structure to nicotine that is found in the tobacco
plant and the Solanaceae family of plants (i.e., green toma-
toes, eggplant, and peppers). Recent studies have observed
anti-inflammatory effects of ANA [11,12]. For example,
ANA lowered NFkB activation and limited amyloid beta
production, both of which are associated with plaque
deposits in the brain, in Alzheimer’s disease [11] and the
over-production of brain inflammatory cytokines [12].
ANA has also been shown to prevent the production of
interleukin-1 beta (IL-1β), interleukin 6 (IL-6), and tumor
necrosis factor alpha (TNF-α) induced by lipopolysac-
charides in human blood and in mice [12]. Theoretically,
therefore, ANA may attenuate the decreases in muscle
strength following eccentric-induced muscle damage by
reducing inflammation and the production of pro-
inflammatory cytokines, since muscle strength is commonly
identified as the single best non-invasive indicator of
muscle damage [2]. For instance, Beck et al. [13] demon-
strated attenuated losses in muscle strength with protease
supplementation following eccentric-induced muscle dam-
age, which was explained by the potential anti-inflamma-
tory effects of the protease supplement. Therefore, using
the same experimental model as Beck et al. [13], the pur-
pose of this study was to examine the effects of ANA sup-
plementation on the recovery of isometric strength and
selected non-invasive indicators of muscle damage. A sec-
ond objective was to assess the effects of short-term ANA
supplementation on heart rate and blood pressure.
We hypothesized that ANA would attenuate losses in
muscular strength and improve the recovery of the
hanging joint angle, relaxed arm circumference, and sub-
jective pain ratings due to its potential anti-inflammatory
properties. We also hypothesized that ANA supplementa-
tion would result in moderate decreases in blood pressure
and small increases in heart rate because of its similar
chemical structure to nicotine [14].
Methods
Participants
Twenty men (mean ± SD age = 22.4 ± 3.0 yrs; body mass =
79.4 ± 15.5 kg; height = 182.9 ± 6.5 cm) volunteered to par-
ticipate in this investigation, which was approved by the
university Institutional Review Board for the protection of
human participants. Two men consumed less than 70% of
the study product and were subsequently considered non-
compliant and excluded from data analysis. Therefore,
only the data from the 18 compliant men (mean ± SD
age = 22.2 ± 3.1 yrs; body mass = 79.7 ± 16.1 kg; height =
182.9 ± 6.5 cm) were analyzed and reported for this
study. Prior to any testing at visit 1, participants signed an
informed consent form and completed a health history
questionnaire. Each participant was free from current or
ongoing neuromuscular diseases or musculoskeletal injur-
ies involving the wrist, elbow, and shoulder joints. None
of the participants had acute infections nor had they en-
gaged in any upper-body resistance training during the
6 months prior to enrollment. In addition, none of the
participants reported smoking, use of smokeless tobacco,
or use of creatine within 9 weeks prior to enrollment. All
of the participants were instructed to maintain their nor-
mal dietary habits and avoid the use of anti-inflammatory
or pain medications throughout the duration of the study.
Experimental design
This study used a randomized, double-blinded, placebo-
controlled, crossover design (Figure 1). At visit 1, the
participants were randomly assigned to either a supple-
ment (anatabine, ANA) or placebo (PLA) condition
based on their assigned participant number and corre-
sponding randomization code. The participants returned
to the laboratory for visit 2 seven days (± 1 day) after
visit 1, and data were recorded for unilateral maximal
voluntary isometric forearm flexion strength, hanging
joint angle, relaxed arm circumference, and subjective
pain rating. Each of these tests was performed immedi-
ately prior to (PRE), immediately following (POST), and
24, 48, and 72 h after the bout of maximal eccentric iso-
kinetic forearm flexion exercise (Figure 1). Following a
washout period of 2–4 weeks, participants returned for
visit 6 to undergo either the ANA or PLA condition,
whichever was not administered during visits 1–5. Dur-
ing the crossover (visits 6–10), the participants per-
formed the same series of tests as visits 1–5. The
dependent variables in this study were maximal
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voluntary isometric forearm flexion strength, hanging
joint angle, relaxed arm circumference, and subjective
pain rating measured during visit 2–5 and visits 7–10,
while resting systolic and diastolic blood pressure and
resting heart rate were only measured at baseline and
72 h (visits 1, 5, 6, and 10). Figure 1 displays the numeric
order of tests performed at each visit. The independent
variables in this study were condition (ANA or PLA)
and time (PRE, POST, 24, 48, and 72 h), and both were
within-subjects repeated measures variables.
Supplementation
The ANA and PLA dietary supplements were adminis-
tered as mint-flavored mannitol granulation lozenges.
Each ANA lozenge contained 3 mg of anatabine, 834 IU
vitamin A, and 66 IU vitamin D3. The PLA lozenge
contained everything in the ANA lozenge except for
anatabine and was identical in flavor and appearance to
the ANA lozenge. The participants were given a 10 day
supply of study product (ANA or PLA) at visits 1 and 6
and were instructed to self-administer the lozenges with
food two or three times per day beginning after visit 1
(Figure 1).The schedule for consuming the lozenges
during each 10 day period was as follows: (a) 1 lozenge
at breakfast and lunch on days 1 and 2, (b) 1 lozenge at
breakfast, lunch, and dinner on days 3 and 4, and (c) 2
lozenges at breakfast and 1 at lunch and dinner on days
5–10. Therefore, during the ANA condition, the partici-
pants consumed 6 mg of ANA during days 1 and 2, 9 mg
during days 3 and 4, and 12 mg during days 5 through 10.
The participants did not take any study product during
the washout period of two to four weeks (Figure 1).
Compliance was assessed when all unused study prod-
uct was returned to the laboratory at visits 5 and 10.
The amount of unused product was counted and used
to calculate compliance. The average compliance was
(mean ± standard deviation) 95.3 ±7.7%, and compliance
ranged between 74% and 104% for all 18 participants.
Figure 1 Schematic of the testing schedule for visits 1–5 and visits 6–10. Testing was performed before (PRE), immediately after (POST), and
24, 48, and 72 h after the eccentric exercise. *The order of tests are numbered sequentially.
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Eccentric exercise protocol
During visits 2 and 7 (Figure 1), the participants com-
pleted an eccentric exercise protocol that consisted of 6
sets of 10 maximal eccentric isokinetic muscle actions
of the forearm flexors at 30° s-1. The exercised arm
(right or left) used during visit 2 was determined at visit
1 using a separate randomization, and the opposite arm
was exercised at visit 7. Connolly et al. [15] reported
that about of eccentric exercise in one limb does not
confer a protective effect against muscle damage in the
opposite limb two weeks later.
Participants were placed in a supine position on an upper
body exercise testing bench with a strap placed around the
waist to prevent excessive movement (Figure 2). The ec-
centric muscle actions were performed with a neutral
hand position. One min of rest was given between each
set. Strong verbal encouragement was provided through-
out the protocol to ensure that a maximal effort was given.
Following the eccentric exercise protocol, 2 min of rest
was provided prior to the POST exercise assessments.
Isometric strength
Participants were placed on an upper body exercise
testing bench as previously described (Figure 2).
Following a warm-up of 5 submaximal muscle actions
at 50% of maximal effort, the participants performed
two 6-s maximal voluntary isometric muscle actions
(MVICs) of the forearm flexors separated by 2 min of
rest. The MVICs were performed with a neutral hand
position. Torque was recorded with a calibrated iso-
kinetic dynamometer (Cybex 6000, CYBEX Division,
LUMEX Inc., Ronkonkoma, NY). Prior to the isometric
muscle actions, the limb was weighed and gravity
corrected using HUMAC software (HUMAC2009, CSMi,
Stoughton, MA). During the isometric muscle actions,
the joint angle between the arm and forearm was set at
115° (65° from full extension), and the angle between
the arm and trunk was set at 45° (45° of abduction). In
order to remove any free play from the dynamometer
lever arm, the investigator placed a minimal baseline
pressure on the lever arm prior to the initiation of the
MVICs. Careful instruction was given to each partici-
pant to ensure that they contracted as “hard and fast”
as possible. The highest torque output (Nm) provided
by the HUMAC software for the two MVICs was de-
fined as the peak torque (PT) and was used for subse-
quent analyses.
Hanging joint angle and relaxed arm circumference
The hanging joint angle (°) between the forearm and
arm was measured using a standard goniometer (Smith
and Nephew Rolyan Inc., Menomomee Falls, WI)
[1,16]. For each measurement, the axis of rotation of
the elbow joint was aligned with the axis of the goni-
ometer. The proximal arm of the goniometer was
aligned with the acromion process of the scapula and
the distal arm was aligned with the styloid process of
the ulna. Relaxed arm circumference (cm) was measured
with a Gulick tape (Mabis Healthcare, Waukegan, IL) [16]
at half the distance between the acromion process of the
scapula and the olecranon process of the ulna. The max-
imum girth was determined with the arm horizontally
abducted and the forearm extended. The hanging joint
angle and relaxed arm circumference were always mea-
sured on the exercised arm prior to completing the MVIC,
except during the POST assessments at visits 2 and 7
(Figure 1) when hanging joint angle and relaxed arm cir-
cumference were measured after the MVIC.
Subjective pain rating
An arm pain intensity scale adapted from McHugh and
Tetro [17] was used to examine the subjective pain rat-
ing in the forearm flexors of the exercised arm as de-
scribed by Beck et al. [13]. The scale ranged from 0 (no
pain at all) to 10 (extremely intense pain). The partici-
pants were presented the scale and asked to identify a
single score for arm pain with the arm relaxed and hang-
ing at the participant’s side. The subjective pain rating
was assessed prior to MVIC, except during the POST as-
sessments at visits 2 and 7 (Figure 1) when the subject-
ive pain rating was assessed after the MVIC.
Resting blood pressure and resting heart rate
The resting blood pressure and resting heart rate were
measured after the participant had been sitting quietly for
a period of at least 5 minutes prior to any other testing.
Figure 2 An example of participant positioning during a
maximal voluntary isometric muscle action.
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Systolic and diastolic resting blood pressure were mea-
sured in mmHg with an aneroid sphygmomanometer
(MDF Instruments, Agoura Hills, CA) and a stethoscope
(Marshall Nurse Stethoscope, Riverside, IL) according to
the procedures described by Housh et al. [18]. Resting
heart rate was measured by palpating the radial artery at
the anterior-lateral surface of the wrist in line with the
base of the thumb, just medial to the styloid process of the
radius. Once the pulse was located, the number of beats
that occurred in 30 s was measured and multiplied by two
to calculate the resting heart rate (bpm).
Statistical analyses
Four separate two-way repeated measures analyses of
variance (ANOVAs) (condition [ANA vs. PLA] x time
[PRE vs. POST vs. 24 h vs. 48 h vs. 72 h]) were used to
analyze PT, hanging joint angle, relaxed arm circum-
ference, and subjective pain rating. Three separate two-
way repeated measures ANOVAs (condition [ANA vs.
PLA] × time [PRE vs. 72 h]) were used to analyze sys-
tolic blood pressure, diastolic blood pressure, and rest-
ing heart rate. When appropriate, follow-up analyses
included one-way repeated measures ANOVAs and
Bonferonni-corrected dependent samples t-tests. All
statistical analyses were performed using IBM SPSS v.
21 (Chicago, IL), and a type I error rate of 5% was con-
sidered statistically significant for all comparisons.
Results
There were no condition x time (p > 0.05) interactions, there
were no main effects for condition (p > 0.05), but there
were main effects for time for PT (p < 0.001), hanging
arm joint angle (p < 0.001), relaxed arm circumference
(p < 0.001), and subjective pain rating (p < 0.001). The
marginal means for PT (collapsed across condition) de-
creased (p < 0.001) from PRE to POST, increased (p =
0.001) from POST to 24 h, and then plateaued (p > 0.05)
from 48 h to 72 h (Figure 3a). The marginal means for
hanging joint angle (collapsed across condition) de-
creased (p < 0.001) from PRE to POST and then did not
change (p > 0.05) from POST to 72 h (Figure 3b). The
marginal means for relaxed arm circumference (col-
lapsed across condition) increased from PRE to POST
(p < 0.001) and then plateaued (p > 0.05) from POST to
72 h (Figure 3c). The marginal means for subjective
pain ratings (collapsed across condition) increased (p <
0.001) from PRE to POST, but did not change (p > 0.05)
from POST to 72 h (Figure 3d).
There were no condition x time (p > 0.05) interactions
and no main effects for condition (p > 0.05) or time (p >
0.05) for systolic blood pressure (Figure 4a), diastolic blood
pressure (Figure 4b), or resting heart rate (Figure 4c).
Discussion
The results of the present study did not support our ori-
ginal hypotheses that ANA would improve the recovery
of PT, hanging joint angle, relaxed arm circumference,
or subjective pain ratings compared to PLA in response
to eccentric-induced muscle damage. The protocol used
in the present study has been used to elicit muscle dam-
age in previous studies [6,13,19,20]. For example, Beck
et al. [13] demonstrated 21-43% decreases in PT of the
forearm flexors, while Cockburn et al. [20] reported 15-
20% decreases in leg flexion PT. The 23-44% decreases
in PT observed in the present study were consistent with
Beck et al. [13], but greater than Cockburn et al. [20],
which may have been related to the muscle group stud-
ied. Nevertheless, Warren et al. [2] suggested that PT is
the single best non-invasive indicator of muscle damage
resulting from eccentric exercise, therefore, the results
of the present study suggested that the magnitude of
muscle damage that occurred was consistent with or
greater than previous studies using the same protocol.
Interestingly, these previous studies [13,20] and others
[10] have also demonstrated that this muscle damage
protocol has elicited decreases in PT that were sensitive
to dietary supplement interventions to improve recovery.
However, in the present study there were no differences
between ANA and PLA conditions during the recovery of
PT, hanging joint angle, relaxed arm circumference, or
subjective pain rating within 72 h after eccentric exercise.
Thus, our conclusion was that ANA supplementation had
no effect on recovery of muscle strength, joint stiffness,
arm swelling, or pain using this model of muscle damage.
Connelly et al. [10] demonstrated that 8 days of cherry
juice supplementation attenuated losses in isometric
forearm flexion PT following a bout of eccentric exercise
when compared with a placebo. The authors [10] hy-
pothesized that the preservation of strength was likely
due to the anti-inflammatory and antioxidant properties
of the cherry juice. Similarly, Beck et al. [13] showed less
reductions in isometric forearm flexion PT after eccen-
tric exercise when participants supplemented with prote-
ase enzymes compared to placebo. Beck et al. [13]
hypothesized that the improved recovery may have been
caused by decreases in acute inflammation as a result of
improved return of interstitial fluid to the bloodstream
and decreased production of prostaglandins with pro-
tease supplementation. In contrast, Rawson et al. [21]
failed to show an effect of creatine supplementation on
the recovery of isometric forearm flexion strength fol-
lowing eccentric exercise. The authors [21] hypothesized
that the mechanical loads placed on the muscle were too
great for creatine to display any membrane-stabilizing
effects. Likewise, the results of the current study indi-
cated that there were no differences between the ANA
and PLA conditions for the decreases in and recovery of
Jenkins et al. Journal of the International Society of Sports Nutrition 2013, 10:33 Page 5 of 8
http://www.jissn.com/content/10/1/33
PT following the eccentric exercise protocol. It is pos-
sible, however, that ANA may reduce inflammation
under other physiological conditions. For example, obes-
ity and aging are associated with increased baseline sys-
temic inflammation that is driven by greater secretion of
pro-inflammatory cytokines compared to young, healthy
individuals [22-24]. Future studies should examine the
effects of ANA on the inflammation associated with
obesity and aging.
Studies on the effects of ANA in animal models
[11,12] have demonstrated that ANA exerts anti-
inflammatory effects via inhibition of Signal Trans-
ducer and Activator of Transcription 3 (STAT3) and
NFkB phosphorylation. It has also been shown [12]
that ANA may reduce pro-inflammatory cytokine (i.e.
TNF-α, IL-6, and IL-1β) production. Despite evidence
that ANA has anti-inflammatory effects [12], as well as
evidence that dietary supplementation may improve
the recovery of strength after eccentric-induced muscle
damage [10,13], ANA supplementation had no dis-
cernable effect on PT or the other measures of muscle
function following eccentric-induced muscle damage.
It is possible that the pathways by which ANA may
elicit anti-inflammatory effects may not influence
the recovery of muscle function following eccentric-
induced muscle damage. Future studies should investi-
gate the effects of ANA on pro-inflammatory cytokine
responses after eccentric exercise.
Eccentric-induced muscle damage may cause muscle
shortening without neural activation as a result of cal-
cium leakage from the sarcoplasmic reticulum [1]. It has
also been suggested [25] that the movement of cells and
fluid from the circulation into the interstitial spaces
surrounding muscle fibers results in inflammation and
edema after eccentric exercise. Therefore, previous stud-
ies have utilized the hanging joint angle [10,13] and
relaxed arm circumference [1,13,16], respectively, as
markers of eccentric-induced muscle damage. However,
when these indices have been used to assess the ability
of dietary supplements to enhance recovery after heavy
eccentric exercise, they have been unable to detect a
treatment effect [10,13]. Muscle soreness, assessed by
the subjective pain rating in the present study, is one of
the most commonly used measures of exercise-induced
muscle injury [2]. However, Warren et al. [2] suggested
that soreness correlates poorly with muscle function. In
the current study, the patterns of recovery for hanging
joint angle, relaxed arm circumference, and subjective
pain ratings were similar in the ANA and PLA condi-
tions (Figure 3b). Therefore, the lack of effect of sup-
plementation on the hanging joint angle and relaxed
arm circumference in these studies [10,13], the poor
correlation between muscle function and soreness [2],
and the results of the present study have collectively
suggested that these indicators of muscle damage may
not be sensitive to dietary supplement interventions to
Figure 3 Recovery of the non-invasive measures of muscle function. Data presented are means ± standard error of the mean for (a)
isometric forearm flexion strength (Nm), (b) hanging joint angle (°), (c) relaxed arm circumference (cm), and (d) subjective pain ratings during the
supplement (dashed line, open circles; ANA) and placebo (solid line, closed circles; PLA) conditions assessed before (PRE), immediately after
(POST), and 24 h, 48 h, and 72 h after a bout of maximal eccentric exercise. For the marginal means (collapsed across condition), *PRE > POST,
24 h, 48 h, and 72 h (p < 0.05); †POST < PRE, 24 h, 48 h, and 72 h (p < 0.05); #PRE < POST, 24 h, 48 h, and 72 h (p < 0.05).
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improve recovery from eccentric-induced muscle dam-
age. Future studies may wish to consider these findings
when selecting outcome variables for assessing the effi-
cacy of dietary supplementation for reducing muscle
damage.
A secondary objective of this study was to examine the
effects of 10 days of ANA dietary supplementation on
resting heart rate and blood pressure. As a minor alkal-
oid with a similar chemical structure to nicotine, we hy-
pothesized that ANA would cause moderate decreases
in systolic and diastolic blood pressure and small in-
creases in resting heart rate. Previous studies [14,26,27]
have shown that acute nicotine exposure causes an
increase heart rate and blood pressure through stimula-
tion of the sympathetic nervous system. Minami et al.
[28] showed that smoking cessation caused a reduction
in heart rate, which implied that chronic nicotine use
may elevate heart rate. However, cross sectional studies
[26,29] have shown that systolic and diastolic blood
pressures are lower in smokers than in non-smokers. The
results of the present study indicated that, over a period of
10 days, ANA had no effect on heart rate or blood pres-
sure compared to placebo. Thus, ANA supplementation
may be safe regarding short-term use (10 days) on resting
heart rate and blood pressure. However, future studies
may wish to examine the acute and chronic effects of
ANA consumption on blood pressure and heart rate to
further discern its safety.
Conclusions
In conclusion, ANA supplementation had no effect on the
recovery of muscle strength, hanging joint angle, arm
swelling, or subjective pain ratings after a bout of maximal
eccentric exercise in the forearm flexors. Therefore, ANA
Figure 4 Heart rate and blood pressure. Data presented are means ± standard error of the mean for (a) systolic blood pressure (mmHg), (b)
diastolic blood pressure (mmHg), and (c) heart rate (bpm) during the supplement (dashed line, open circles; ANA) and placebo (solid line, closed
circles; PLA) conditions assessed at baseline (visits 1 or 6)and 72 h after the bout of maximal eccentric exercise.
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may not be beneficial for those seeking to improve recov-
ery from heavy exercise training or competition. Future
studies, however, should examine the effects of ANA on
the pro-inflammatory cytokine responses to eccentric-
induced muscle damage. It is also possible that, due to the
pathways by which ANA exerts its anti-inflammatory
properties, ANA supplementation may have an effect on
chronic, low-grade inflammation such as the inflammation
observed in obese and elderly individuals.
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